| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Alto Neuroscience, Inc. | Director | Stock Option (right to buy) | 15,287 | $79,998 | $3.17 | 13 May 2025 | Direct |
| Newsmax Inc. | Director | Option (Right to Buy) | 17,500 | 28 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ANRO | Alto Neuroscience, Inc. | 13 May 2025 | 1 | $0 | 4 | Director | 15 May 2025, 16:16 |
| NMAX | Newsmax Inc. | 28 Mar 2025 | 1 | $0 | 4 | Director | 04 Apr 2025, 06:18 |
| NMAX | Newsmax Inc. | 28 Mar 2025 | 0 | $0 | 3 | Director | 28 Mar 2025, 15:47 |
| ANRO | Alto Neuroscience, Inc. | 02 Jan 2025 | 1 | $79,998 | 4 | Director | 06 Jan 2025, 16:17 |
| ANRO | Alto Neuroscience, Inc. | 06 Feb 2024 | 4 | $0 | 4 | Director | 07 Feb 2024, 16:39 |
| ANRO | Alto Neuroscience, Inc. | 01 Feb 2024 | 2 | $54,939 | 4 | Director | 05 Feb 2024, 16:42 |
| ANRO | Alto Neuroscience, Inc. | 01 Feb 2024 | 0 | $0 | 3 | Director | 01 Feb 2024, 18:47 |